AOAC CASP Meeting

9/7/2019

With cannabinoids like CBD crossing into General Retail, we project a ~$45B  US Total Cannabinoid Market in 2024

Rx cannabinoids

Projected US Total Cannabinoid Revenues ($B)

%

Non‐THC  cannabinoids in  general retail

$2B $13B

Other cannabinoids in  licensed dispensaries

$5B

$25B

%

$0.6B $1.2B

THC cannabinoids in  licensed dispensaries

$9B

2018

2024

THC Disp Non‐THC cannabinoids Rx

Source: BDS Analytics/Arcview Market Research 

29

2018 BDS Analytics | CONFIDENTIAL

We project dramatic growth driven especially by growth in general retail  channels

BDS Analytics’ Projected US Channel Drivers of cannabinoids sales growth ($B) $20 +$4 +$12 +$2.2

$1.9

2018

General Retail

Dispensary

Pharma

2024

Source: BDS Analytics CBD Market Monitor

2018 BDS Analytics | CONFIDENTIAL

15